CST3 and chronic kidney disease: In the population-based cohorts, cystatin C-based CKD prevalence was much higher in older adults, whereas in the diseased cohorts CKD-EPIcrea resulted in a higher CKD prevalence in participants aged 65 years or older, especially in females.